In March 2025, the company introduced new programs for just a immediate-to-client providing of its Wegovy weight loss drug. The company recognized a different pharmacy, called NovoCare, which might charge clients $499 each month for entry to the drug, a lot less than 50 percent the cost of the drug through other pharmaceutical distribution networks